NYSE CRTR Economy Event Watch the replay →

Advertisement
Advertisement

PBEvsPJPETF Comparison

ETF 1
PBE

Invesco Dynamic Biotechnology & Genome ETF

This fund is part of
BioTech & Genomics
-0.39%
VS
ETF 2
PJP

Invesco Dynamic Pharmaceuticals ETF

This fund is part of
US Health Care
-0%

Invesco Dynamic Biotechnology & Genome ETF (PBE) belongs to the BioTech & Genomics segment. Invesco Dynamic Pharmaceuticals ETF (PJP) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. PBE is more expensive with a Total Expense Ratio (TER) of 0.58%, versus 0.57% for PJP. PBE is up 2.54% year-to-date (YTD) with -$3M in YTD flows. PJP performs better with 9.21% YTD performance, and +$8M in YTD flows. Run a side-by-side ETF comparison of PBE and PJP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PBE vs PJP performance and flow charts

Performance

-4.0-2.00.02.04.06.0%May 12May 19May 27Jun 3Jun 10

Cumulative Flows

0 M10 M20 M30 M40 M50 M60 MMay 12May 19May 27Jun 3Jun 10

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 06/12/2026
1M3MYTD1Y3Y5Y
Perf.
PBE
PJP
+1.33%+6.64%
+10.39%+11.01%
+2.54%+9.21%
+31.31%+39.89%
+34.96%+55.84%
+10.44%+47.29%
Flows
PBE
PJP
+$2M-$4M
-$3M-$81M
-$3M+$8M
-$26M+$17M
-$56M-$63M
-$45M-$112M
Volatility and drawdown
3M1Y3Y5Y
Volatility
PBE
PJP
+19.82%+19.18%
+19.09%+16.60%
+20.14%+15.81%
+22.41%+16.19%
Max drawdown
PBE
PJP
-4.08%-4.05%
-11.70%-9.42%
-22.21%-16.11%
-34.74%-17.41%
Max drawdown duration
PBE
PJP
16d7d
156d108d
324d275d
1540d788d
Trading data

Create an account to view trading data

Join for free
PBE
PJP
Last sale
6/12/2026 at 1:30 PM
$84.10
$113.85
Previous close
06/11/2026
$84.82
$113.83
Consolidated volume
06/11/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of May 29, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
PBE
PJP
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 6/12/2026 at 1:30 PM
Live
Closed
PBE
PJP
Last price
$84.10
$113.85
1D performance
-0.85%
+0.02%
AuM$259.85 M$350.52 M
E/R0.58%0.57%
Characteristics
PBE
PJP
Management strategyPassivePassive
ProviderInvescoInvesco
BenchmarkDynamic Biotech & Genome Intellidex IndexDynamic Pharmaceutical Intellidex Index
N° of holdings3029
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJune 23, 2005June 23, 2005
ESGNoNo
Advertisement
Exposure

Countries

PBE
USA
92.2%
Other
7.8%
PJP
USA
94.24%
Other
5.76%

Sectors

PBE
Health Care
97.78%
Other
2.22%
PJP
Health Care
100%
Other
0%
Advertisement

Diversification

PBE

Total weight of top 15 holdings out of 15

62.95%
PJP

Total weight of top 15 holdings out of 15

62.71%

Top 15 holdings

Data as of April 30, 2026
PBE
UTD THERAPEUT
6.20%
ILLUMINA
5.42%
REGENERON PHARMACEUTICALS
4.99%
INCYTE
4.91%
ALNYLAM PHARMACEUTICALS
4.80%
BIOGEN INC
4.80%
AMGEN-T
4.60%
GILEAD SCIENCES
4.48%
CATALYST PHARMACEUTICALS INC
3.42%
BIOCRYST PHARMACEUTICALS
3.30%
TG THERAPEUTICS
3.28%
ARROWHEAD PHARMACEUTICALS INC
3.27%
CAREDX INC/D
3.21%
PROTAGONIST THERAPEUTICS INC
3.18%
ROYALTY PHARMA
3.09%
PJP
PFIZER
5.28%
JOHNSON&JOHNSON
4.90%
MERCK & CO INC
4.76%
AMGEN-T
4.75%
GILEAD SCIENCES
4.63%
ABBVIE
4.62%
LILLY
4.46%
ABBOTT LABS
4.33%
TRAVERE THERAPEUTICS INC
3.91%
LIGAND PHARMACEUTICALS
3.79%
CORCEPT THERAPEUTICS
3.75%
UTD THERAPEUT
3.55%
JAZZ PHARMACEUTICALS
3.43%
LIQUIDIA CORPORATION
3.29%
HARMONY BIOSCIENCES HLDG
3.26%
Frequently asked questions about PBE and PJP

How have the PBE and PJP ETFs performed in 2026?

As of June 12, 2026, PBE is up 2.54% year-to-date (YTD), while PJP has returned 9.21%. That puts PJP better performer ahead so far this year.

Which ETF is attracting more investor money: PBE or PJP?

Year-to-date, the PBE ETF saw -$3M in flows, compared to +$8M for PJP.

Which ETF is more volatile: PBE or PJP?

Over the past year, PBE had a volatility of 19.09%, while PJP experienced 16.6%.

Which ETF is bigger: PBE or PJP?

As of June 12, 2026, PBE holds $259.85 M in assets under management (AUM), while PJP manages $350.52 M.

What sectors do the PBE and PJP ETFs invest in?

PBE leans toward sectors like Health Care. Meanwhile, PJP focuses on Health Care.

What are the top holdings of the PBE ETF and PJP ETF?

PBE top holdings include UTD THERAPEUT, ILLUMINA and REGENERON PHARMACEUTICALS. PJP holds in its top three: PFIZER, JOHNSON&JOHNSON and MERCK & CO INC.

Which ETF is more diversified: PBE or PJP?

PBE holds 30 securities with 62.95% of its assets in the top 15. PJP has 29 securities and a top 15 weight of 62.71%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up